8-K - Lipocine Inc. (0001535955) (Filer)
Published . Updated .
Filed: 2026-10-07 AccNo: 0001493152-26-046060 Size: 329 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- LPCN Lipocine
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-07 AccNo: 0001493152-26-046060 Size: 329 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Lipocine (LPCN)
Since the first closing price after “8-K - Lipocine Inc. (0001535955) (Filer),” Lipocine (LPCN) is -19.17%. The S&P 500 fund (SPY) is -0.94% over the same days, a -18.23% difference versus the market.
Who gains and who loses around Lipocine (LPCN)
Companies mentioned with this story
- LPCN Lipocine
In “8-K - Lipocine Inc. (0001535955) (Filer),” Lipocine (LPCN) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> LPCN
How “8-K - Lipocine Inc. (0001535955) (Filer)” reaches Lipocine (LPCN)
On 7 Oct 2026, “8-K - Lipocine Inc. (0001535955) (Filer)” is the story that connects Lipocine (LPCN) to this story.
The link for Lipocine (LPCN) is this: SEC 8-K filing -> direct issuer disclosure -> LPCN
The price range for Lipocine (LPCN), and the dates in the story
LPCN traded between 1.40 and 3.12 across 10 sessions. The latest close on file is 1.56.
How strong the case is around Lipocine (LPCN)
14 out of 100
“8-K - Lipocine Inc. (0001535955) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.